Ashwagandha

The single best-evidenced "adaptogen" for anxiety and stress reduction. Multiple double-blind RCTs (KSM-66 and Sensoril extracts) show ~30% cortisol reductions and meaningful PSS/HAM-A score improvements. Testosterone effect is real in older or stressed men (~10-20% increase) but weak in young athletes. Two main standardized extracts dominate the market: KSM-66 (root only, ~5% withanolides, more pro-energy/T-skewed reports) and Sensoril (root + leaf, ~10% withanolides, more sedating). For Dylan: low priority as a daily core; STRONG-CANDIDATE for stress-prone archetypes.

Ashwagandha root and leaf contain >35 withanolides — steroidal lactones structurally similar to cardiac glycosides. The active fraction varies by extract:

Standardization differences (matters more than people think):

• KSM-66: Root-only extract, standardized to ~5% withanolides; typically dosed 300-600 mg/day. Reputation for being more "pro-energy," less sedating, more thoroughly studied for testosterone and athletic outcomes (Wankhede 2015, Lopresti 2019).
• Sensoril: Root + leaf extract, standardized to ~10% withanolides; typically dosed 125-250 mg/day. Reputation for more anxiolytic / sleep-deepening effects; trial base also strong (Auddy 2008, Salve 2019).
• Shoden: Root + leaf extract standardized to ~35% withanolides; very high potency; typically dosed 60-120 mg/day. Newer entrant, sleep trial data growing.
• Generic ashwagandha: Variable potency, often unstandardized — research findings don't necessarily transfer.

Mechanism dimensions:

1. GABAergic anxiolysis: Withaferin A and withanolide A bind weakly at the GABA-A receptor benzodiazepine site (much weaker than benzos but real). This contributes to the felt calming and sleep effect.

2. HPA-axis modulation: Reduces cortisol release in response to chronic stress without flatlining the diurnal rhythm. Multiple RCTs show 14-32% reductions in serum or salivary cortisol with 60-day dosing in stressed populations.

3. Testosterone (modest, contextual):

• In stressed/anxious men or men with subfertility: KSM-66 reproducibly raises total T by 10-20% over 8-16 weeks (Ambiye 2013 — n=46 infertile men, +17%; Lopresti 2019 — n=57 overweight aged 40-70, +14%).
• In young trained athletes: Wankhede 2015 — n=57 young men 18-50 on resistance training, +15% total T over 8 weeks. Real but modest.
• The gain is largely cortisol-mediated (reduced cortisol → improved T:C ratio) and via reduced SHBG.

4. Thyroid: Ashwagandha can raise TSH-driven T3/T4 modestly. Beneficial in subclinical hypothyroidism (Sharma 2018 RCT confirmed); concerning in hyperthyroid patients.

5. Neuroprotection (theoretical): Withaferin A activates Nrf2; withanolide A increases BDNF in animal stress models; some evidence for hippocampal neurogenesis support. Translation to humans uncertain.

6. Immune modulation: Withaferin A is a known immunomodulator — caution in autoimmune populations (theoretical risk of flares, anecdotally reported).